This knowledge could also yield avenues for therapeutic intervention in diseases associated with aberrant assembly of these proteins, such as FUS-associated ALS (fALS-FUS) and frontotemporal lobar degeneration (FTLD-FUS). This evidence concerns the gene FUS and amyotrophic lateral sclerosis.